Concepedia

Deborah Hunter

DH

Statistics

Publications

39

Citations

6.6K

H-Index

31

Active since

1977

Affiliations

Incyte (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of Florence

York District Hospital

Hôpital Saint-Louis

Deborah Hunter is an author at Incyte (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1977–2023

39

Publications

39

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali et al. · New England Journal of Medicine · 2012 · 1.8K citations · Full text

, , +10

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

Stuart P. Weisberg, Deborah Hunter, Reid Huber et al. · Journal of Clinical Investigation · 2005 · 1.5K citations · Full text

, , +17

Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

Elena A. Goncharova, Dmitry A. Goncharov, Andrew Eszterhas et al. · Journal of Biological Chemistry · 2002 · 430 citations · Full text

, , +17

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis

Francisco Cervantes, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian et al. · Blood · 2013 · 425 citations · Full text

, , +4

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed

Herbert I. Hurwitz, Nikhil Uppal, Stephanie A. Wagner et al. · Journal of Clinical Oncology · 2015 · 287 citations · Full text

, , +16

1–5 of 39